Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Clinical trial NCT04614103 · RECRUITING
Trial details
- NCT number
- NCT04614103
- Sponsor
- Iovance Biotherapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-07
- Primary completion
- 2030-12-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.